Acino International AG - Strategic SWOT Analysis Review

September 2021 | 31 pages | ID: A6D096E58C8EN
GlobalData

Abstracts

Acino International AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Acino International AG (Acino), formerly Acino Holding AG, manufactures and commercializes generic and prescription pharmaceuticals in novel drug delivery forms. The company focuses on the therapeutic areas of oncology, cardiology and metabolism, central nervous system, gastroenterology, infectiology, pain and rheumatology, respiratory, urology and women’s health, among others. It also offers business-to-business services such as product development and contract manufacturing, among others. The company's drug delivery technologies focus on modified release oral forms and oral dispersible forms. Acino has manufacturing facilities in Estonia, Switzerland and Ukraine. The company markets products mainly in the Middle East, Latin America, Africa, Europe and Asia. Acino is headquartered in Zurich, Switzerland.

Acino International AG Key Recent Developments

Aug 19,2021: Merz Therapeutics and Acino sign distribution agreement in Ukraine, CIS and Mongolia
Nov 18,2020: AFT opening European office, signs new partners for Maxigesic IV and Oral range
Mar 10,2020: H.H. Sheik Hamdan bin Rashid welcomes Acino Chief Executive Officer Steffen Saltofte in Dubai
Feb 06,2020: Acino Receives EU GMP Certification in Ukraine

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Acino International AG - Key Facts
Acino International AG - Key Employees
Acino International AG - Key Employee Biographies
Acino International AG - Major Products and Services
Acino International AG - History
Acino International AG - Company Statement
Acino International AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Acino International AG - Business Description
Acino International AG - SWOT Analysis
SWOT Analysis - Overview
Acino International AG - Strengths
Acino International AG - Weaknesses
Acino International AG - Opportunities
Acino International AG - Threats
Acino International AG - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Acino International AG, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Acino International AG, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Aug 19, 2021: Merz Therapeutics and Acino sign distribution agreement in Ukraine, CIS and Mongolia
Nov 18, 2020: AFT opening European office, signs new partners for Maxigesic IV and Oral range
Mar 10, 2020: H.H. Sheik Hamdan bin Rashid welcomes Acino Chief Executive Officer Steffen Saltofte in Dubai
Feb 06, 2020: Acino Receives EU GMP Certification in Ukraine

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Acino International AG, Key Facts
Acino International AG, Key Employees
Acino International AG, Key Employee Biographies
Acino International AG, Major Products and Services
Acino International AG, History
Acino International AG, Subsidiaries
Acino International AG, Key Competitors
Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Acino International AG, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Acino International AG, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Acino International AG, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021